SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-118991
Filing Date
2023-11-16
Accepted
2023-11-16 11:16:17
Documents
1
Group Members
ASTRAZENECA HOLDINGS B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2330912d1_sc13da.htm SC 13D/A 46296
  Complete submission text file 0001104659-23-118991.txt   48065
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013
Business Address 8 RUE DE LA CROIX JARRY PARIS, LLE-DE-FRANCE I0 75013 33181691600
Cellectis S.A. (Subject) CIK: 0001627281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89356 | Film No.: 231413085
SIC: 2836 Biological Products, (No Diagnostic Substances)